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Recently, the American Heart Association (AHA) adopted a new and ambitious strategic goal -"by 2020, to improve the cardiovascular health of all Americans by 20% while reducing deaths from cardiovascular disease by 20%". 1 In the process, it defined a new concept, cardiovascular health, which is comprised of 7 components: 4 ideal health behaviors (nonsmoking, body mass index < 25 kg/m 2 , physical activity at goal levels, and a diet consistent with current recommendations) together with 3 ideal health factors (untreated total cholesterol < 200mg/dL, untreated blood pressure <120/<80 mm Hg, and fasting blood glucose<100 mg/dL). This new approach emphasizes prevention with a focus on achieving and sustaining desirable behaviors.
At the time of the AHA report, the health benefits of each of the 7 individual components were well-supported by available literature. A few studies had also defined the relationship of clusters of ideal levels of risk factors and behaviors and had assessed their relationship with health outcomes, quality of life, and cost. [2] [3] [4] [5] [6] Specifically, Stamler defined low cardiovascular risk as a cluster of optimal levels of traditional cardiovascular risk factors, 3 while Stampfer defined a cluster of ideal lifestyle behaviors. 4 Yet, in 2010, when the AHA published its 2020 strategic goal, there was no available research on the new metric, cardiovascular health. In this issue of Circulation, two papers address this gap and provide complementary data related to cardiovascular health, or at least a forme fruste. The principal finding of the Liu study was a graded, direct relationship -the more HLF in young adulthood, the greater the prevalence of low (desirable) CVD risk profile at middle age, 20 years later. Specifically, the prevalence of a low CVD risk profile increased progressively from only 0-3% in those with 0-1 HRF to 60.7% in those with 5+ HLFs. In the whole cohort, the overall prevalence of a low CVD risk profile dropped from 43.7% at the baseline examination to 24.5% at year 20. Some of their most interesting findings related to potential impact of adopting HRFs.
Among those who had < 4 HLFs at all time points (years 0, 7, and 20), the prevalence of a low CVD profile was only 14.4% at year 20. Among adopters, namely those who initially had < 4
HLFs at baseline but who subsequently had 4+ HLF at year 7, year 20, or both years, the prevalence was strikingly higher (27.1%, 38.9% and 43.2%, respectively).
The study by Ford and colleagues 8 levels of the 7 components. Ultimately, we selected stringent, evidence-based thresholds to define ideal levels. Interestingly, neither study used the explicit definition of cardiovascular health that the Task Force proposed. Each study modified aspects of the cardiovascular health metric, specifically, the definition of ideal diet, physical activity, as well as the definition of diabetes. Some of the variance might have resulted from the data collection tools used at the inception of these studies. With this in mind, I urge those who design our national surveys and major cohort studies to collect the requisite data to define cardiovascular health, as originally proposed, and to report their findings accordingly. Use of the recommended, albeit stringent thresholds, will facilitate comparisons across studies and progress over time. The bar is high, and appropriately so.
Achieving cardiovascular health is also extraordinarily relevant to two contemporary public heath goals -eliminating health disparities and improving population health. While there is widespread recognition of racial and geographic disparities in health, 9 there is emerging evidence that factors which comprise the cardiovascular health metric are likely responsible for these racial disparities. In a recent analysis, it was estimated that disparities in four factors (smoking, blood pressure, blood glucose, and adiposity) explained well over half of the racial differences in cardiovascular mortality in the United States. 10 Lastly, cardiovascular health is closely related to population health, a popular concept among policy makers. The factors which determine cardiovascular health also appear to determine noncardiovascular outcomes as well. Additional support comes from the analyses by Ford and colleagues, in which there was a strong dose-response relationship between the number of ideal by guest on April 15, 2017 http://circ.ahajournals.org/ Downloaded from levels of the cardiovascular metrics with all-cause mortality, not just mortality from diseases of the circulatory system. 8 Importantly, achieving population health is now viewed as a critical component of health care reform, not just for the sake of improving health but also as a means to control costs. As Daviglus and colleagues documented in the Chicago Heart Study, low cardiovascular risk at middle age is associated with reduced Medicare costs at older aged. 2, 6 It will be important to replicate such analyses using the ideal cardiovascular health metric and to do so in broader samples and with other estimates of cost, potentially lifetime costs.
In summary, the studies by Liu and Ford provide strong empiric support for cardiovascular health as a valid construct. Efforts must now focus on interventions that assist individuals and populations in achieving and sustaining cardiovascular health, which hopefully will become the default, rather than the exception.
